Clinical Genomics

-- Article outlines advantages and provides further data to support the use of COLVERA for assessing response to treatment and risk of disease progression – -- Study finds that a COLVERA positive ctDNA result after completion of treatment…

BRIDGEWATER, N.J., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Clinical Genomics, a provider of cancer diagnostic solutions, including liquid biopsy tests for molecular residual disease (“MRD”) and recurrence monitoring of colorectal cancer…